Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

117.84
Delayed Data
As of Jul 02
 +0.27 / +0.23%
Today’s Change
51.93
Today|||52-Week Range
140.00
+21.48%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 144.50, with a high estimate of 180.00 and a low estimate of 110.00. The median estimate represents a +22.62% increase from the last price of 117.84.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.74
Sales
$13.0M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.68%
 
 
 
 
 
 
Growthannually 38.24%
 
 
 
 
 
 

Sales

Growthquarterly -29.87%
 
 
 
 
 
 
Growthannually 16.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account